Rocaglamide Selectively Eradicates Human Leukemia Stem Cells and Synergizes with Multiple Agents to Target AML Cells

被引:0
|
作者
Callahan, Kevin P. [1 ]
Corbett, Cheryl [1 ]
Jacob, Steven
Minhajuddin, Mohammad [1 ]
Lagadinou, Eleni D. [1 ]
Rossi, Randall M. [1 ]
Gross, Valerie [1 ]
Balys, Marlene [1 ]
Hagen, Fred [2 ]
Frontier, Alison J.
Jordan, Craig T. [1 ]
机构
[1] Univ Rochester, Med Ctr, Wilmot Canc Ctr, Rochester, NY 14642 USA
[2] Univ Rochester, Med Ctr, Prote Core, Rochester, NY 14642 USA
关键词
D O I
10.1182/blood.V120.21.1338.1338
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1338
引用
收藏
页数:2
相关论文
共 50 条
  • [11] STEM CELLS IN HUMAN AML
    Majeti, Ravi
    EXPERIMENTAL HEMATOLOGY, 2024, 137
  • [12] Small-Molecule Ferroptotic Agents with Potential to Selectively Target Cancer Stem Cells
    William R. Taylor
    Sara R. Fedorka
    Ibtissam Gad
    Ronit Shah
    Hanan D. Alqahtani
    Radhika Koranne
    Nishanth Kuganesan
    Samkeliso Dlamini
    Tim Rogers
    Ayad Al-Hamashi
    Veronika Kholodovych
    Yusuf Barudi
    Damian Junk
    Maisha S. Rashid
    Mark W. Jackson
    L. M. Viranga Tillekeratne
    Scientific Reports, 9
  • [13] Small-Molecule Ferroptotic Agents with Potential to Selectively Target Cancer Stem Cells
    Taylor, William R.
    Fedorka, Sara R.
    Gad, Ibtissam
    Shah, Ronit
    Alqahtani, Hanan D.
    Koranne, Radhika
    Kuganesan, Nishanth
    Dlamini, Samkeliso
    Rogers, Tim
    Al-Hamashi, Ayad
    Kholodoyych, Veronika
    Barudi, Yusuf
    Junk, Damian
    Rashid, Maisha S.
    Jackson, Mark W.
    Tillekeratne, L. M. Viranga
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [14] Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2
    Bing Xu
    Shiyun Wang
    Rongwei Li
    Kai Chen
    Lingli He
    Manman Deng
    Vinodh Kannappan
    Jie Zha
    Huijuan Dong
    Weiguang Wang
    Cell Death & Disease, 2017, 8 : e2797 - e2797
  • [15] A Novel Lair-1 Antibody Selectively Targets Acute Myeloid Leukemia (AML) Stem Cells
    Tian, Linjie
    Paucarmayta, Ana
    Lovewell, Rustin
    Maloveste, Karla
    Hong, Junshik
    Hedgepath, Carly
    Kim, Kwang Woon
    Copeland, Ron
    O'Neill, Thomas
    Patel, Shashank
    Liu, Linda N.
    Myint, Han
    Langermann, Solomon
    Flies, Dallas B.
    Kim, Tae Kon
    BLOOD, 2021, 138
  • [16] Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-kB and Nrf2
    Xu, Bing
    Wang, Shiyun
    Li, Rongwei
    Chen, Kai
    He, Lingli
    Deng, Manman
    Kannappan, Vinodh
    Zha, Jie
    Dong, Huijuan
    Wang, Weiguang
    CELL DEATH & DISEASE, 2017, 8 : e2797 - e2797
  • [17] Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
    Jones, Courtney L.
    Stevens, Brett M.
    D'Alessandro, Angelo
    Reisz, Julie A.
    Culp-Hill, Rachel
    Nemkov, Travis
    Pei, Shanshan
    Khan, Nabilah
    Adane, Biniam
    Ye, Haobin
    Krug, Anna
    Reinhold, Dominik
    Smith, Clayton
    DeGregori, James
    Pollyea, Daniel A.
    Jordan, Craig T.
    CANCER CELL, 2018, 34 (05) : 724 - +
  • [18] Lysosomotropic agents selectively target chronic lymphocytic leukemia cells due to altered sphingolipid metabolism
    R F Dielschneider
    H Eisenstat
    S Mi
    J M Curtis
    W Xiao
    J B Johnston
    S B Gibson
    Leukemia, 2016, 30 : 1290 - 1300
  • [19] Leukemia stem cells as therapeutic target
    Pabst, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 62 - 62
  • [20] Lysosomotropic agents selectively target chronic lymphocytic leukemia cells due to altered sphingolipid metabolism
    Dielschneider, R. F.
    Eisenstat, H.
    Mi, S.
    Curtis, J. M.
    Xiao, W.
    Johnston, J. B.
    Gibson, S. B.
    LEUKEMIA, 2016, 30 (06) : 1290 - 1300